Home › Research › Prevention and risk
The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers
Wei BZ, Li L, Dong CW, Tan CC, Alzheimer's Disease Neuroimaging Initiative, Xu W. American Journal of Clinical Nutrition, 2023-04-05
Topic: Risk, prevention and care in population studies
Plain-language summary
Previous data have linked omega-3 fatty acids with risk of dementia. We aimed to assess the longitudinal relationships of omega-3 polyunsaturated fatty acid intake as well as blood biomarkers with risk of Alzheimer's disease (AD), dementia, or cognitive decline. Longitudinal data were derived from 1135 participants without dementia (mean age = 73 y) in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort to evaluate the associations of omega-3 fatty acid supplementation and blood biomarkers with incident AD during the 6-y follow-up. A meta-analysis of published cohort studies was further conducted to test the longitudinal relationships of dietary intake of omega-3 and its peripheral markers with all-cause dementia or cognitive decline. Causal dose-response analyses were conducted using the robust error meta-regression model. In the ADNI cohort, long-term users of omega-3 fatty acid supplements exhibited a 64% reduced risk of AD (hazard ratio: 0.36, 95% confidence interval: 0.18, 0.72; P = 0.004). After incorporating 48 longitudinal studies involving 103,651 participants, a moderate-to-high level of evidence suggested that dietary intake of omega-3 fatty acids could lower risk of all-cause dementia or cognitive decline by ∼20%, especially for docosahexaenoic acid (DHA) intake (relative risk [RR]: 0.82, I 2 = 63.6%, P = 0.001) and for studies that were adjusted for apolipoprotein APOE ε4 status (RR: 0.83, I 2 = 65%, P = 0.006). Each increment of 0.1 g/d of DHA or eicosapentaenoic acid (EPA) intake was associated with an 8% ∼ 9.9% (P linear 2 = 38.1%) and erythrocyte membrane DHA (RR: 0.94, I 2 = 0.4%) were associated with a lower risk of cognitive decline. Dietary intake or long-term supplementation of omega-3 fatty acids may help reduce risk of AD or cognitive decline.
What this study adds
Evidence grade: Moderate
This is a pooled review of 103,651 participants. This analysis of cohort studies found that higher omega-3 intake and higher blood markers were linked to lower risk of dementia and cognitive decline. Its stated limit: Observational data with moderate heterogeneity (I2 up to 65%); supplement users may differ in health behaviours; randomised supplement trials have generally been less positive.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wei, B. Z., Li, L., Dong, C. W., Tan, C. C., Alzheimer's Disease Neuroimaging Initiative, & Xu, W. (2023). The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers. American Journal of Clinical Nutrition. https://doi.org/10.1016/j.ajcnut.2023.04.001
Vancouver
Wei BZ, Li L, Dong CW, Tan CC, Alzheimer's Disease Neuroimaging Initiative, Xu W. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers. American Journal of Clinical Nutrition. 2023. doi:10.1016/j.ajcnut.2023.04.001. PMID: 37028557.
BibTeX
@article{wei2023-37028557,
author = {Wei, B. Z. and Li, L. and Dong, C. W. and Tan, C. C. and {Alzheimer's Disease Neuroimaging Initiative} and Xu, W.},
title = {{The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers}},
journal = {American Journal of Clinical Nutrition},
year = {2023},
doi = {10.1016/j.ajcnut.2023.04.001},
pmid = {37028557},
url = {https://doi.org/10.1016/j.ajcnut.2023.04.001}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- After incorporating 48 longitudinal studies involving 103,651 participants, a moderate-to-high level of evidence suggested that dietary intake of omega-3 fatty acids could lower risk of all-cause dementia or cognitive decline by ∼20%, especially for docosahexaenoic acid (DHA) intake (relative risk [RR]: 0.82, I 2 = 63.6%, P = 0.001) and for studies that were adjusted for apolipoprotein APOE ε4 status (RR: 0.83, I 2 = 65%, P = 0.006).
- Each increment of 0.1 g/d of DHA or eicosapentaenoic acid (EPA) intake was associated with an 8% ∼ 9.9% (P linear 2 = 38.1%) and erythrocyte membrane DHA (RR: 0.94, I 2 = 0.4%) were associated with a lower risk of cognitive decline.
Why it matters
This analysis of cohort studies found that higher omega-3 intake and higher blood markers were linked to lower risk of dementia and cognitive decline. It is observational, so it cannot prove that omega-3 supplements or fish oil prevent Alzheimer's disease.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designmeta-analysis
- Participants103,651
- Effect sizeDietary DHA intake RR 0.82 for dementia or cognitive decline; ADNI supplement users HR 0.36 (95% CI 0.18-0.72) for Alzheimer's
- Evidence strengthModerate
Limitations
Observational data with moderate heterogeneity (I2 up to 65%); supplement users may differ in health behaviours; randomised supplement trials have generally been less positive.
How this study scored 74/100
Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. We have no data on free to read, so that was left out: it earned 73 of the 98 points we could judge it on, which is 74 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (American Journal of Clinical Nutrition) |
| Journal's citation record | 3 / 4 | American Journal of Clinical Nutrition: journal h-index 499 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 4 / 4 | 103,651 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 5 / 7 | Cited 169 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 33.8 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 5 / 6 | Cited 24.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 3 / 4 | Cited 163 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Wei Xu: h-index 42 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Qingdao University: institution h-index 430 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37028557) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 73 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 73 of the 98 points we could judge it on is 74 out of 100. |
| Total | 74 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.ajcnut.2023.04.001
- PubMed: 37028557
- Original source →
- Free full text: PubMed Central →
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.
Later studies that cite this one
5 studies in the alzhub library list this one in their references.
Related studies in Prevention and risk from nearby years
Also tagged “omega-3-supplements-and-cognition”
3 studies in the library carry the topic tag “omega-3-supplements-and-cognition”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 3 tagged studies.